Guillain-Barre syndrome observed with adoptive transfer of lymphocytes genetically engineered with an NY-ESO-1 reactive T-cell receptor
Abstract Background Adoptive transfer of autologous T-lymphocytes transduced with a high affinity NY-ESO-1-reactive T-cell receptor (NY-ESO-1c259 T-cells) has emerged as a promising therapeutic strategy for patients with refractory synovial sarcoma. Secondary autoimmune T-cell mediated toxicities ca...
Main Authors: | Jocelyn Joseph, Michael J. Nathenson, Van Anh Trinh, Karan Malik, Erica Nowell, Kristen Carter, Shiao-Pei Weathers, George D. Demetri, Dejka Araujo, Anthony P. Conley |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2019-11-01
|
Series: | Journal for ImmunoTherapy of Cancer |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s40425-019-0759-x |
Similar Items
-
Systemic and local immunity following adoptive transfer of NY-ESO-1 SPEAR T cells in synovial sarcoma
by: Indu Ramachandran, et al.
Published: (2019-10-01) -
Síndrome de Guillain-Barré
by: Sergio Luis Montes de Oca, et al.
Published: (2014-04-01) -
Síndrome de Guillain-Barré
by: Giselle Maria Beneti, et al.
Published: (2006-05-01) -
Immune landscape and in vivo immunogenicity of NY-ESO-1 tumor antigen in advanced neuroblastoma patients
by: Chiara Camisaschi, et al.
Published: (2018-10-01) -
Evaluation of Production Protocols for the Generation of NY-ESO-1-Specific T Cells
by: Wenjie Gong, et al.
Published: (2021-01-01)